BALDRY MARK (Chief Commercial Officer) purchased 4.2% of their position (1.03K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market purchase worth $2.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2025ACC: 0001628280-25-026864
Officer· Chief Commercial Officer
Since Nov 2022
+1.03K
Net shares
Net buyer
$2.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.03K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.03K
Price / share
$2.48
Trade value
$2.56K
% of position
4.2%
5/16/2025
24.30K→25.34K
Total
Net shares
+1.03K
Net value
$2.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | P · Purchase | +1.03K | $2.48 | $2.56K | 4.2% | 24.30K | 25.34K |
| Total | +1.03K | $2.56K | ||||||
Derivative Transactions0
No derivative transactions reported